Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(11/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(11/week)
News
United States
(530/week)
Manufacturing
(352/week)
Energy
(282/week)
Technology
(363/week)
Other Manufacturing
(284/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Hepatitis
Mar 06, 2020
European Commission Grants AbbVie Marketing Authorization Shortening MAVIRET® (glecaprevir/pibrentasvir) Treatment Duration to Eight Weeks for Treatment-Naïve Chronic HCV Patients with Genotype 3 and Compensated Cirrhosis
Mar 05, 2020
Zydus Announces World's First Drug for the Treatment of Non-Cirrhotic NASH
Mar 05, 2020
Galmed Pharmaceuticals to Report Fourth Quarter and Year End 2019 Financial Results and Provide Business Update on Thursday March 12
Mar 03, 2020
DURECT Corporation Announces Fourth Quarter and Full Year 2019 Financial Results and Update of Programs
Feb 25, 2020
Clinical Study Supports Bergacyn® for Liver and Vascular Health
Feb 19, 2020
ChemomAb Ltd. Announces Issuance of Composition of Matter Patent for CM-101 and Reinforces its IP Portfolio
Feb 17, 2020
Ascletis' IND Filing for Its Non-alcoholic Steatohepatitis (NASH) Drug Accepted by NMPA
Feb 12, 2020
Liminal BioSciences Announces Scientific Presentations at Upcoming Keystone Symposia
Feb 12, 2020
Antios Therapeutics Initiates First-in-Human Phase I Study of ATI-2173
Feb 06, 2020
ProSciento and Nordic Bioscience Form Strategic Partnership to Develop Translational Biomarkers for Nonalcoholic Steatohepatitis (NASH)
Jan 30, 2020
Novel Coronavirus: In Vitro Diagnostics Brought to Bear
Jan 28, 2020
Enzychem Lifesciences Appoints Dr. Michael Charlton To Its Scientific Advisory Board
Jan 22, 2020
Ascletis Received Approval of Clinical Trials in HBV Patients for ASC22, a Subcutaneously Administered PD-L1 Antibody
Jan 22, 2020
Metacrine Demonstrates Best-in-Class FXR Drug Program with Positive Clinical Results in NASH Patients
Jan 13, 2020
Akero Therapeutics Expands Phase 2a Trial in NASH to Include Cohort of Cirrhotic Patients
Dec 16, 2019
Akero Therapeutics Completes Enrollment in Phase 2a Study in NASH
Dec 10, 2019
Liver Health Supplements Market Size Worth $948.61 Million by 2025: Grand View Research, Inc.
Nov 21, 2019
Enzychem Lifesciences Presents EC-18 NASH Development Update at The Liver Meeting 2019
Nov 19, 2019
Viking Therapeutics Announces Initiation of Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH)
Nov 13, 2019
J. Craig Venter Institute and UC San Diego Develop Phage Treatment as Potential Cure for Alcoholic Liver Disease
‹‹
Page 2
››
Latest News
Apr 20, 2024
Biloxi Marsh Lands Corporation Announces Unaudited Results for the First Quarter of 2024
Apr 20, 2024
Evergy Schedules Conference Call to Discuss 1st Quarter Results
Apr 20, 2024
Stem Announces Appointment of AI Industry Leader as New Independent Director
Apr 20, 2024
Clarification of Details Regarding Oceansix's Engagement with RB Milestone Group LLC
Apr 20, 2024
Eaton to announce first quarter 2024 earnings on April 30, 2024
Apr 20, 2024
Permianville Royalty Trust Announces Monthly Operational Update
Apr 20, 2024
Novanta to Present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024
Apr 20, 2024
nVent Electric plc to Release First Quarter 2024 Financial Results and Host Earnings Conference Call on...
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events